TheSenior Managerof Cell and GeneTherapyCommercial Supply Chainwilldriveslotmanagementoperationsto support Vertex’sautologouscell and gene therapyprogram.Theslot managementmodelincludesdynamic,shortrange, andsituationalplanning and operationsto allowvisibility andpatient scheduling.TheSenior Managerwillbe responsible forestablishing,maintaining, revising, andexecutingslotmanagementrules and principlesto ensure patients are appropriately scheduledwithinmanufacturingcapacity and regulatory requirements.This includes chairingCDMO andcross-functional meetings anddrivingcontent ofkey presentations to cross-functional leaders. Through cross-functional alignment, theSenior Managerwill drive thedataused in thecreation,maintenance, and usageofaKey PerformanceIndicators(KPIs)Dashboard. In this role, theSenior Managerwillberesponsible forcreating business processes and opportunities to ensure capacity utilization across the Supply Chain network.This includes representation as key Supply Chain lead for cross-functional workstreamsand initiatives.TheSenior Managerwill work closely withkey stakeholdersincludingtheFinance,Regulatory,Commercial,Logistics, Manufacturing,and Vertex’s Cell and Gene Therapy Site.
Strong written and verbal communication skills to exchange relevant, and at times complex, information cross-functionally and ensuring understanding
$133,600 - $200,400
The range provided is based on what we believe is a reasonable estimate for the base salary pay range for this job at the time of posting. This role is eligible for an annual bonus and annual equity awards. Some roles may also be eligible for overtime pay, in accordance with federal and state requirements. Actual base salary pay will be based on a number of factors, including skills, competencies, experience, and other job-related factors permitted by law.
At Vertex, our Total Rewards offerings also include inclusive market-leading benefits to meet our employees wherever they are in their career, financial, family and wellbeing journey while providing flexibility and resources to support their growth and aspirations. From medical, dental and vision benefits to generous paid time off (including a week-long company shutdown in the Summer and the Winter), educational assistance programs including student loan repayment, a generous commuting subsidy, matching charitable donations, 401(k) and so much more.
Hybrid-Eligible Or On-Site Eligible
In this Hybrid-Eligible role, you can choose to be designated as:
Note: The Flex status for this position is subject to Vertex’s Policy on Flex @ Vertex Program and may be changed at any time.
#LI-Hybrid
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases. The company has approved medicines that treat the underlying causes of multiple chronic, life-shortening genetic diseases — cystic fibrosis, sickle cell disease and transfusion-dependent beta thalassemia — and continues to advance clinical and research programs in these diseases. Vertex also has a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where it has deep insight into causal human biology, including APOL1-mediated kidney disease, acute and neuropathic pain, type 1 diabetes, myotonic dystrophy type 1 and alpha-1 antitrypsin deficiency.
Founded in 1989 in Cambridge, Mass., Vertex's global headquarters is now located in Boston's Innovation District and its international headquarters is in London. Additionally, the company has research and development sites and commercial offices in North America, Europe, Australia, Latin America and the Middle East. Vertex is consistently recognized as one of the industry's top places to work, including 14 consecutive years on Science magazine's Top Employers list and one of Fortune’s 100 Best Companies to Work For. For company updates and to learn more about Vertex's history of innovation, visit[**www.vrtx.com**](https://cts.businesswire.com/ct/CT?id=smartlink&url=http%3A%2F%2Fwww.vrtx.com&esheet=52609949&newsitemid=20220321005939&lan=en-US&anchor=www.vrtx.com&index=2&md5=a32693d2c9354cbbd5ad1e43dab9dd40) or follow us on [Facebook](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.facebook.com%2FVertexPharmaInc%2F&esheet=52018237&newsitemid=20190725005107&lan=en-US&anchor=Facebook&index=2&md5=3f9f17b728f89efc65b40de59acf2d0a), __[Twitter/X](https://twitter.com/VertexPharma)_ _,[ LinkedIn](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.linkedin.com%2Fcompany%2Fvertex-pharmaceuticals%2F&esheet=52018237&newsitemid=20190725005107&lan=en-US&anchor=LinkedIn&index=4&md5=e0cefd5734e34af1f803797ede89db22), [YouTube](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.youtube.com%2Fchannel%2FUCrNu_QIE9exwVQnWKgr1toQ&esheet=52018237&newsitemid=20190725005107&lan=en-US&anchor=YouTube&index=5&md5=34abd524fab4d94b88eb3150d656a2b3) and [Instagram](https://cts.businesswire.com/ct/CT?id=smartlink&url=https%3A%2F%2Fwww.instagram.com%2Fvertexpharmaceuticals%2F&esheet=52018237&newsitemid=20190725005107&lan=en-US&anchor=Instagram&index=6&md5=b119baee5b0dcc2e8af2b4f43a74356f). _
The diversity and authenticity of our people is part of what makes Vertex unique, and we recognize that each employee brings diverse perspectives and strengths. By embracing those strengths and celebrating differences, we are fostering an inclusive culture where each of us can bring our authentic selves to work, inspire innovation together, and change people’s lives.
Our vision is clear: to be the place where an authentic, diverse mix of talent want to come, to stay, and do their best work.
Vertex is a global biotechnology company that invests in scientific innovation to create transformative medicines for people with serious diseases and has made significant advancements in cystic fibrosis, sickle cell disease, transfusion-dependent beta thalassemia, and acute pain — and continues to progress clinical and research programs in these diseases. We also have a robust clinical pipeline of investigational therapies across a range of modalities in other serious diseases where we have deep insight into causal human biology, including acute and neuropathic pain, APOL1-mediated kidney disease, IgA nephropathy, autosomal dominant polycystic kidney disease, type 1 diabetes and myotonic dystrophy type 1. Our global headquarters is in Boston, and we have research and development (R&D) sites and commercial offices worldwide. Vertex is consistently recognized as one of the industry’s top places to work by Science Magazine, The Boston Globe, Boston Business Journal and the San Diego Business Journal. We have also earned a spot on TIME Most Influential Companies, TIME Best Inventions, and Fast Company Most Innovative Companies lists. Our research and medicines have received esteemed recognitions, including the Robert J. Beall Therapeutics Development Award, the Prix Galien, the Scrip Award and the Breakthrough Prize awards. Read our community guidelines: https://www.vrtx.com/vertexs-community-guidelines/
View company profile →